Lung cancer remains a significant global health concern, with India contributing a notable share. It accounts for 5.9% of all cancers and 8.1% of all cancer-related deaths in the country. This rise can be attributed to increasing tobacco use, air pollution, and occupational hazards.

The burden on patients and their families is immense, as the disease often leads to severe symptoms such as persistent cough, chest pain, shortness of breath, and weight loss. In advanced stages, lung cancer can spread, further complicating the condition and decreasing quality of life. Financial stress from treatment costs also adds to the challenges, particularly in low-income communities.

Treatment Approaches for Lung Cancer

Lung cancer treatment depends on the stage of the disease and the patient's health. Surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy are commonly used treatments. Radiation therapy, which uses high-energy radiation to destroy cancer cells, plays a key role in lung cancer management.

However, the approach varies significantly between the two main types of lung cancer: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Understanding the Types of Lung Cancer

Before exploring radiation therapy differences, it’s crucial to understand the types of lung cancer:

- Non-Small Cell Lung Cancer (NSCLC): The most common type, making up about 85% of cases, which includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.

- Small Cell Lung Cancer (SCLC): A less common but highly aggressive form that often spreads rapidly.

Radiation Therapy for Non-Small Cell Lung Cancer (NSCLC)

Radiation therapy for NSCLC is often combined with surgery or chemotherapy. The specific approach depends on the cancer stage and the patient's health. Key techniques include:

- External Beam Radiation Therapy (EBRT): High-energy beams are directed at the tumor from outside the body. This can shrink the tumor, relieve symptoms, or prevent cancer spread.

- Stereotactic Body Radiation Therapy (SBRT): A highly precise method that delivers a large dose of radiation in just a few treatments, typically used for early-stage NSCLC when surgery isn't an option.

- Brachytherapy: Radioactive seeds or implants are placed directly into the tumor, particularly useful for tumors blocking airways.

Radiation Therapy for Small Cell Lung Cancer (SCLC)

SCLC is primarily treated with a combination of chemotherapy and radiation therapy, with the goal of shrinking the tumor and controlling its spread. Common approaches include:

- Concurrent Chemoradiotherapy: Chemotherapy and radiation therapy are given simultaneously, often as the first-line treatment for extensive-stage SCLC.

- Induction Chemotherapy Followed by Radiation Therapy: Chemotherapy is first administered to shrink the tumor, followed by radiation therapy to target the cancerous area.

Key Differences Between NSCLC and SCLC Radiation Therapy

- Treatment Goals: For NSCLC, the goal is often to cure or control the cancer's growth, whereas for SCLC, the aim is to control the disease and improve survival rates.

- Combination Therapies: NSCLC may be treated with radiation alone or combined with surgery or chemotherapy, while SCLC usually involves a combination of chemotherapy and radiation therapy.

- Treatment Intensity: Radiation for NSCLC is generally less intense compared to SCLC, given the aggressive nature of SCLC.

- Treatment Duration: SCLC radiation therapy tends to be shorter compared to NSCLC, though this varies based on cancer stage and type.

Prophylactic Cranial Irradiation (PCI) for SCLC

SCLC can metastasize to the brain. After chemoradiotherapy, patients may receive prophylactic cranial irradiation (PCI) to the brain, which can help in achieving a cure.

It’s important to remember that these are general guidelines, and treatment plans are customized based on the type of cancer, stage, and patient’s overall health. If you or someone you know has been diagnosed with lung cancer, it’s crucial to consult a medical professional for the most suitable treatment options.

Disclaimer: The views expressed in this article are of the author and not of Health Dialogues. The Editorial/Content team of Health Dialogues has not contributed to the writing/editing/packaging of this article.
Dr Tejinder Kataria
Dr Tejinder Kataria

Dr Tejinder Kataria (MBBS, MD Radiotherapy, DNB Radiotherapy) is the Chairperson of Radiation Oncology & Cancer Care at Medanta Hospital, Gurugram. In her 35 years plus of experience she is credited with founding the Department of Radiation Oncology at both Rajiv Gandhi Cancer Institute, New Delhi, Artemis health Institute, Gurugram and also setting up Division of Radiation Oncology at Medanta-Gurugram. Dr Kataria has studied across premier institutes across India and aboard like PGI Chandigarh, University of Cambridge and University of Loads, Harvard University among others, Dr Kataria has introduced the latest evolutions in radiation treatment to Medanta such Stereotactic Radiosurgery (SRS), Image Guided Radiotherapy (IGRAT), Intensity Modulated Radiotherapy (IMAT) Image Guided Brachytherapy and Total Body irradiation (TBI), Total Skin Electron Therapy (TSET). Dr Kataria has been associated with QUATRO Asia team from International Atomic Energy Agency, Vienna, since 2005 and was part of Task Force Committee for National Cancer Control program from 11th year plan under Ministry of Health and Family Welfare, New Delhi.